Exports In 2023, Ecuador exported $1.44M in Vaccines, blood, antisera, toxins and cultures, making it the 97th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 219th most exported product in Ecuador. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Ecuador are: Peru ($775k), Colombia ($337k), Bolivia ($148k), Chile ($49.1k), and Kenya ($20k).
The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Ecuador between 2022 and 2023 were Bolivia ($98.3k), Kenya ($18.4k), and China ($9.72k).
Imports In 2023, Ecuador imported $258M in Vaccines, blood, antisera, toxins and cultures, becoming the 64th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 18th most imported product in Ecuador. Ecuador imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($52.9M), Germany ($43.9M), South Korea ($20.2M), Switzerland ($18.8M), and Ireland ($13.3M).
The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Ecuador between 2022 and 2023 were Germany ($7.37M), Ireland ($5.88M), and Australia ($3.87M).